Article
Challenges in the design of a T cell vaccine in the context of HIV-1 diversity.
Viruses - 23 Oct 2014
Tongo Marcel, Burgers Wendy A
Abstract excerpt
The extraordinary variability of HIV-1 poses a major obstacle to vaccine development. The effectiveness of a vaccine is likely to vary dramatically in different populations infected with different HIV-1 subtypes, unless innovative vaccine immunogens are developed to protect against the range of HIV-1 diversity. Immunogen design for stimulating neutralizing antibody responses focuses on "breadth" - the targeting...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
